| Revision as of 18:42, 3 December 2011 editDJBostrom (talk | contribs)1 edit →Missing BSL-3 Site: new section← Previous edit | Revision as of 02:58, 4 December 2011 edit undoMiszaBot I (talk | contribs)234,552 editsm Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.Next edit → | ||
| Line 8: | Line 8: | ||
| |archive = Talk:Biosafety level/Archive %(counter)d | |archive = Talk:Biosafety level/Archive %(counter)d | ||
| }} | }} | ||
| == Missing Level 3/4 Facility == | |||
| On the table, there is an entry to say a Level 4 facility is being built in the United Kingdom, but not where, nor who the owner of the building/land is currently. Most likely to be the DSTL or even QinetiQ, although the latter is highly unlikey. Perhaps a research university such as Oxford, Cambridge, Birmingham or perhaps Imperial College? (unsigned) | |||
| Looks like it's fixed now. AFAIK it is now 100% correct relating to the UK however I would expect more at DSTL! --] (]) 11:25, 3 September 2011 (UTC) | |||
| == Hendra virus is NOT a BSL-3 pathogen == | |||
| It is a BSL-4 pathogen. <span style="font-size: smaller;" class="autosigned">—Preceding ] comment added by ] (]) 21:55, 16 December 2010 (UTC)</span><!-- Template:UnsignedIP --> <!--Autosigned by SineBot--> | |||
| == Private BSL-3 facilities abound == | == Private BSL-3 facilities abound == | ||
Revision as of 02:58, 4 December 2011
| This is the talk page for discussing improvements to the Biosafety level article. This is not a forum for general discussion of the article's subject. |
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 14 days  |
 | Medicine C‑class Low‑importance | |||||||||
| ||||||||||
Private BSL-3 facilities abound
Having worked and consulted in the DC area, RTP, Chicago, and at corporate sites around the eastern half of the US, I don't see any way to reasonably assemble a complete list of BSL-3 facilities. None of the ones I've worked at except USAMRIID are on this list; BSL-3 facilities are simply too common. Many vaccine manufacturing and testing facilities exist that can handle the pathogens requiring BSL-3, and most of them are not publicly advertised. The key point for BSL-3 is that treatment exists; if the treatment is derived from the living pathogen, industry will need this facility. While there isn't a West nile, Anthrax, SARS, or yellow fever testing facility on every corner, they are not uncommon enough to have the scarcity noted.
152.14.43.30 (talk) 16:51, 20 April 2011 (UTC) TWM
Similarly having worked in the UK industry designing such facilities, there are BSL-3 labs everywhere, and many, many are omitted from the list. BSL-4 is a different beast altogether and are much scarcer! --PopUpPirate (talk) 11:24, 3 September 2011 (UTC)
REDACTED
My apologies, I was wrong. Nevermind! Salvidrim (talk) 16:51, 21 August 2011 (UTC)
Noguchi Memorial Institute for Medical Research
Revision 456170207 by 197.255.96.5 (talk) added "Noguchi Memorial Institute for Medical Research" (NMIMR) to the External links section, but without any external link, citation, or indication of biosafety levels. I'm moving it to this talk page until the BSL can be confirmed.
The institute is in Ghana, is named after Hideyo Noguchi, and apparently has a BSL-2 or BSL-3 laboratory, or both. Some references:
- Addo, Phyllis; Quartey, Maxwell; Abbas, Mona; Adu-Addai, Benjamin; Owusu, Enid; Okang, Ishmael; Dodoo, Alfred; De Souza, Dziedom; Ankrah, Nii-Ayi; Ofori-Adjei, David (2008), "In-Vitro Susceptibility of Mycobacterium Ulcerans to Herbal Preparations", The Internet Journal of Tropical Medicine, 4 (2), ISSN 1540-2681, retrieved 2011-11-20. Mentions a level 2 biosafety laboratory at NMIMR.
- "Department of Virology". Noguchi Memorial Institute for Medical Research. University of Ghana. Retrieved 2011-11-20.
Good laboratory practices are strictly followed and special training provided for staffs who work in a biosafety level 3 (BSL 3) environment with related pathogens.
- Josephine NKETSIA-TABIRI, Ph.D (2003). Report on “The Survey on Programmes for Safe Use of Biotechnology/Biosafety And Existing Status of Biotechnology And Living Modified Organisms (LMOs) in Ghana” (PDF). National Review Workshop on “Surveys on Biotechnology, Biosafety Programmes and Related Legislation in Ghana”. UNEP-GEF, NBC, and BNARI. p. 44. ISBN 9988-8274-5-8. Retrieved 2011-11-20.
It is note-worthy that the NMIMR of UG has a level 3 pathogen-free laboratory.
85.23.32.64 (talk) 14:36, 20 November 2011 (UTC)
Missing BSL-3 Site
The Biosecurity Research Institute at Kansas State University in Manhattan Kansas has a BSL-3, ABSL-3 (animal BSL-3), BSL-3E (Enhanced BSL-3) and BSL-3Ag facility. It is located next to where the new BSL-4 facility is being built. It is mentioned in the article on the new facility but not listed as having its own BSL-3. This information was gleaned from a job posting on their website. So I assume it is reasonably accurate. DJBostrom (talk) 18:42, 3 December 2011 (UTC)
Categories: